References
The change in energy relative to the baseline time point (0 min) for women between groups. * Significantly different from PLA (The change in sustained energy relative to the baseline time point (0 min) for women between groups. * Significantly different from PLA (The change in concentration relative to the baseline time point (0 min) between groups. PLA: Placebo. ML: Methylliberine. * Significantly different from PLA (The change in motivation relative to the baseline time point (0 min) between groups. PLA: Placebo. ML: Methylliberine. The change in mood relative to the baseline time point (0 min) between groups. PLA: Placebo. * Significantly different from PLA (Participant characteristics.Stroop and Trail Making Test B (TMT-B) scores at baseline (Day 0) and testing visits (Day 4).PLA: Placebo. ML: Methylliberine. * Statistically significant difference from 0 min time point (Feelings of affect via VAS at baseline (Day 0) and testing visits (Day 4).PLA: Placebo. ML: Methylliberine. * Statistically significant difference from 0 min time point (Vitals at baseline (Day 0) and testing visits (Day 4).PLA: Placebo. ML: Methylliberine. SBP: Systolic blood pressure; DBP: Diastolic blood pressure; and PL: Placebo. * Significantly different from 0 min (